91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Attention Deficit Hyperactivity Disorder (ADHD) Market Growth (Status and Outlook) 2025-2031

Global Attention Deficit Hyperactivity Disorder (ADHD) Market Growth (Status and Outlook) 2025-2031

Publication ID: 
LPI08254028
Publication Date: 
August 6, 2025
Pages: 
110
Publisher: 
LPI
Countries: 
Global [1]
USD 3,660.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharmaceutical Manufacturing [2]
Healthcare [3]
Pharma & Healthcare [4]
Description: 

According to this study, the global Attention Deficit Hyperactivity Disorder (ADHD) market size will reach US$ 18340 million by 2031.
Effective treatment of ADHD. ADHD refers to a group of syndromes that occur in childhood and are characterized by obvious difficulty in concentration, short duration of attention, hyperactivity or impulsivity compared with children of the same age.
The ADHD market is expanding rapidly due to rising global awareness and increasing diagnosis rates, especially in children and young adults. Improved understanding of mental health conditions among healthcare providers, educators, and parents has contributed to earlier identification and more proactive treatment approaches. Government-supported initiatives, mental health screenings in schools, and expanded insurance coverage have made ADHD treatment more accessible in both developed and developing regions. Furthermore, advancements in pharmacological research have led to the availability of more effective, long-acting, and better-tolerated medications, expanding the range of treatment options. The rise of digital health platforms, including telemedicine and mobile apps for symptom monitoring, has also made ADHD management more convenient and efficient. Growing adult ADHD diagnosis, driven by increased public discussion and reduced stigma, is further contributing to market growth.
Despite the increasing demand, the ADHD market faces several significant challenges. One of the main concerns is the potential overdiagnosis or misdiagnosis of ADHD, particularly in children, leading to inappropriate or excessive use of medications. Differentiating ADHD from other behavioral or psychological disorders like anxiety, autism, or learning disabilities remains complex, often requiring multidisciplinary assessments. Medication side effects, such as insomnia, appetite suppression, and cardiovascular concerns, can lead to treatment non-compliance or discontinuation. There are also regulatory barriers around stimulant drug prescriptions due to their potential for abuse and dependency. Additionally, disparities in healthcare infrastructure and limited access to trained mental health professionals in low-income and rural areas hinder timely diagnosis and treatment. Cultural stigma around psychiatric disorders still discourages many individuals and families from seeking medical help, especially in emerging markets.
The 鈥淎ttention Deficit Hyperactivity Disorder (ADHD) Industry Forecast鈥� looks at past sales and reviews total world Attention Deficit Hyperactivity Disorder (ADHD) sales in 2024, providing a comprehensive analysis by region and market sector of projected Attention Deficit Hyperactivity Disorder (ADHD) sales for 2025 through 2031. With Attention Deficit Hyperactivity Disorder (ADHD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Attention Deficit Hyperactivity Disorder (ADHD) industry.
This Insight Report provides a comprehensive analysis of the global Attention Deficit Hyperactivity Disorder (ADHD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Attention Deficit Hyperactivity Disorder (ADHD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Attention Deficit Hyperactivity Disorder (ADHD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Attention Deficit Hyperactivity Disorder (ADHD) and breaks down the forecast by Type, by Distribution Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Attention Deficit Hyperactivity Disorder (ADHD).
This report presents a comprehensive overview, market shares, and growth opportunities of Attention Deficit Hyperactivity Disorder (ADHD) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stimulant
Non-stimulant
Segmentation by Distribution Channel:
Hospital Pharmacy
Retail Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Takeda
Johnson & Johnson
Novartis
Eli Lilly
Tris Pharma
Neos Therapeutics
Mallinckrodt
Amneal Pharmaceuticals
Noven Pharmaceuticals
Purdue Parma
Zhengdafenhai
Highland Therapeutics
Jubilant Life Sciences
Medice Arzneimittel Putter
Lannett

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size (2020-2031)
2.1.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Attention Deficit Hyperactivity Disorder (ADHD) by Country/Region (2020, 2024 & 2031)
2.2 Attention Deficit Hyperactivity Disorder (ADHD) Segment by Type
2.2.1 Stimulant
2.2.2 Non-stimulant
2.3 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type
2.3.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Type (2020-2025)
2.4 Attention Deficit Hyperactivity Disorder (ADHD) Segment by Distribution Channel
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.5 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel
2.5.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Size CAGR by Distribution Channel (2020 VS 2024 VS 2031)
2.5.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Distribution Channel (2020-2025)
3 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Player
3.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Size Market Share by Player
3.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Player (2020-2025)
3.1.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Player (2020-2025)
3.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Attention Deficit Hyperactivity Disorder (ADHD) by Region
4.1 Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2020-2025)
4.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth (2020-2025)
4.4 APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth (2020-2025)
4.5 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth (2020-2025)
4.6 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size Growth (2020-2025)
5 Americas
5.1 Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2020-2025)
5.2 Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2020-2025)
5.3 Americas Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Region (2020-2025)
6.2 APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2020-2025)
6.3 APAC Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Country (2020-2025)
7.2 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2020-2025)
7.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) by Region (2020-2025)
8.2 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Type (2020-2025)
8.3 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Distribution Channel (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Region (2026-2031)
10.1.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Region (2026-2031)
10.1.2 Americas Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.1.3 APAC Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.1.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.1.5 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.2 Americas Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Country (2026-2031)
10.2.1 United States Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.2.2 Canada Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.2.3 Mexico Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.2.4 Brazil Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.3 APAC Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Region (2026-2031)
10.3.1 China Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast
10.3.2 Japan Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.3.3 Korea Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.3.4 Southeast Asia Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.3.5 India Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.3.6 Australia Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Country (2026-2031)
10.4.1 Germany Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.4.2 France Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.4.3 UK Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.4.4 Italy Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.4.5 Russia Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.5 Middle East & Africa Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Region (2026-2031)
10.5.1 Egypt Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.5.2 South Africa Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.5.3 Israel Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.5.4 Turkey Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
10.6 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Type (2026-2031)
10.7 Global Attention Deficit Hyperactivity Disorder (ADHD) Forecast by Distribution Channel (2026-2031)
10.7.1 GCC Countries Market Attention Deficit Hyperactivity Disorder (ADHD) Forecast
11 Key Players Analysis
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.1.3 Takeda Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Takeda Main Business Overview
11.1.5 Takeda Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.2.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.3.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.4.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 Tris Pharma
11.5.1 Tris Pharma Company Information
11.5.2 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.5.3 Tris Pharma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Tris Pharma Main Business Overview
11.5.5 Tris Pharma Latest Developments
11.6 Neos Therapeutics
11.6.1 Neos Therapeutics Company Information
11.6.2 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.6.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Neos Therapeutics Main Business Overview
11.6.5 Neos Therapeutics Latest Developments
11.7 Mallinckrodt
11.7.1 Mallinckrodt Company Information
11.7.2 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.7.3 Mallinckrodt Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Mallinckrodt Main Business Overview
11.7.5 Mallinckrodt Latest Developments
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Information
11.8.2 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.8.3 Amneal Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Amneal Pharmaceuticals Main Business Overview
11.8.5 Amneal Pharmaceuticals Latest Developments
11.9 Noven Pharmaceuticals
11.9.1 Noven Pharmaceuticals Company Information
11.9.2 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.9.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Noven Pharmaceuticals Main Business Overview
11.9.5 Noven Pharmaceuticals Latest Developments
11.10 Purdue Parma
11.10.1 Purdue Parma Company Information
11.10.2 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.10.3 Purdue Parma Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Purdue Parma Main Business Overview
11.10.5 Purdue Parma Latest Developments
11.11 Zhengdafenhai
11.11.1 Zhengdafenhai Company Information
11.11.2 Zhengdafenhai Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.11.3 Zhengdafenhai Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Zhengdafenhai Main Business Overview
11.11.5 Zhengdafenhai Latest Developments
11.12 Highland Therapeutics
11.12.1 Highland Therapeutics Company Information
11.12.2 Highland Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.12.3 Highland Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Highland Therapeutics Main Business Overview
11.12.5 Highland Therapeutics Latest Developments
11.13 Jubilant Life Sciences
11.13.1 Jubilant Life Sciences Company Information
11.13.2 Jubilant Life Sciences Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.13.3 Jubilant Life Sciences Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Jubilant Life Sciences Main Business Overview
11.13.5 Jubilant Life Sciences Latest Developments
11.14 Medice Arzneimittel Putter
11.14.1 Medice Arzneimittel Putter Company Information
11.14.2 Medice Arzneimittel Putter Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.14.3 Medice Arzneimittel Putter Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Medice Arzneimittel Putter Main Business Overview
11.14.5 Medice Arzneimittel Putter Latest Developments
11.15 Lannett
11.15.1 Lannett Company Information
11.15.2 Lannett Attention Deficit Hyperactivity Disorder (ADHD) Product Offered
11.15.3 Lannett Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Lannett Main Business Overview
11.15.5 Lannett Latest Developments
12 Research Findings and Conclusion

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/lpi/global-attention-deficit-hyperactivity-disorder-adhd-market-growth-status-and-outlook-2025-2031

Links
[1] /countries/global[2] /pharmaceutical-manufacturing[3] /healthcare[4] /pharma-healthcare